Embla Medical
Embla Medical is a global provider of prosthetics, orthotics, bracing, and patient care services for amputees and people with mobility challenges, operating through the Össur, Fior & Gentz, College Park, and ForMotion brands across approximately 40 countries with USD 929M in 2025 revenue.
- Company typePublic
- Founded1971
- HeadquartersReykjavík, Iceland
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Embla Medical does
Embla Medical hf., headquartered in Reykjavik, Iceland and listed on Nasdaq Copenhagen (ticker: EMBLA), is a global provider of prosthetics, orthotics, bracing and supports, and patient care services for people with limb loss, limb difference, and mobility challenges. The company operates a multi-brand architecture comprising Össur (prosthetics and bracing), Fior & Gentz (neuro orthotics), College Park (lower-limb prosthetics), ForMotion (the global network of patient care clinics), and the more recently acquired Naked Prosthetics (finger and partial-hand prostheses) and Streifeneder ortho.production (orthopedic mobility solutions, 51% majority). Embla's technology portfolio spans microprocessor-controlled knees (POWER KNEE, marketed as the world's first actively powered bionic knee), myoelectric upper-limb devices (i-Limb), carbon-fiber sports blades (Cheetah), silicone interface systems (Iceross, the 1986 first global patent that became standard of care), and intelligent prosthetic feet (Proprio Foot, Pro-Flex, Balance, Odyssey iQ). With over 2,100 registered patents and R&D investment of approximately 5% of annual revenue, the company is the most patent-dense Icelandic life-sciences business, with specialized R&D hubs in Reykjavik, Livingston (Scotland, upper limb), and Olympia, Washington (finger prosthetics).
Embla's business model blends hardware sales (Prosthetics & Neuro Orthotics contributed 51% of 2025 sales at USD 474M; Bracing & Supports contributed 16% at USD 149M) with professional patient-care services through its ForMotion clinic network (33% of 2025 sales at USD 306M). The company sells primarily through direct field sales to O&P clinics, hospitals, and prosthetic providers across ~40 countries, complemented by branded athlete sponsorships (Team Össur) and clinical-channel marketing. 2025 net sales of USD 929M (the highest in the company's history) generated 20% EBITDA margins, USD 84M net profit (up 21%), and USD 100M of free cash flow, with regional split of EMEA 49%, Americas 43%, and APAC 8%. The customer base is structurally long-tail (individual amputees and mobility-impaired patients served through fragmented clinical channels), and pricing is reimbursement-driven. Strategic priorities visible in 2024-2026 include the Streifeneder majority acquisition, a three-year USD 11M partnership with the Government of Iceland to serve Ukrainian amputees via a new Kyiv clinic, leadership refresh (new COO and EVP R&D), and ongoing product launches in the core prosthetics segment.
Embla Medical firmographics
Firmographics- Name
- Embla Medical
- Legal name
- Embla Medical hf.
- Website
- https://emblamedical.com
- Company type
- Public
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Embla Medical is a global provider of prosthetics, orthotics, bracing, and patient care services for amputees and people with mobility challenges, operating through the Össur, Fior & Gentz, College Park, and ForMotion brands across approximately 40 countries with USD 929M in 2025 revenue.
- Ownership category
- akta.pro rank
Embla Medical industry classification
Industry- Product category
- Orthotic and Prosthetic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems) (HLAHAEAH)
- akta.pro secondary industries
- Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets) (HLAHAMAD), Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI), Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics) (HLAHAMAJ), Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)
Keywords
Where Embla Medical is headquartered
LocationHeadquarters
- HQ city
- Reykjavík
- HQ country
- Iceland
- HQ region
- Europe
Offices7 records
Markets served
Embla Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Prosthetics & Neuro Orthotics Products: Design, manufacture and sale of prosthetic devices including microprocessor knees, feet, sports blades, and upper limb prosthetics, as well as neuro orthotic solutions. Contributed 51% of 2025 sales (USD 474 million).
- Bracing & Supports: Bracing and support solutions for mobility assistance. Contributed 16% of 2025 sales (USD 149 million).
- Patient Care Services: Patient care services through global network of ForMotion O&P clinics providing prosthetic fitting, rehabilitation and ongoing patient care. Contributed 33% of 2025 sales (USD 306 million).
- Strategic Acquisitions: Growth through acquisitions including Streifeneder ortho.production (51% majority stake) and Naked Prosthetics, expanding product portfolio and market reach.
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
Embla Medical product offering
Product offeringCore offering
Embla Medical designs, manufactures, and sells prosthetic limbs, neuro orthotic devices, and bracing & supports products through brands including Össur, Fior & Gentz, College Park, and Naked Prosthetics. The company also operates a global network of ForMotion Orthotic & Prosthetic patient care clinics providing prosthetic fitting, rehabilitation, and ongoing patient care services.
Product overview
Embla Medical is a leading global provider of innovative mobility solutions offering a comprehensive portfolio across prosthetics, neuro orthotics, bracing & supports, and patient care. The company operates under a platform-plus-brands architecture, unified under the Embla Medical parent company. Key brands include Össur (prosthetics and bracing solutions), Fior & Gentz (neuro orthotics), College Park (lower limb prosthetics), and ForMotion (global patient care clinic network). The company also acquired Naked Prosthetics to expand upper limb offerings. Products span from microprocessor-controlled knees (POWER KNEE™) and running blades (Cheetah®) to myoelectric hands (i-Limb®), prosthetic feet (Pro-Flex, Balance™), and neuro orthotic devices, supported by a global network of patient care clinics.
Differentiator
Problem solved
Functional benefit
Brands
- Össur: Leading global provider of prosthetics and bracing & supports solutions. Core brand for lower limb prosthetics including Cheetah sports blades, POWER KNEE, and i-Limb upper limb prostheses.
- Fior & Gentz
- College Park
- ForMotion
- Naked Prosthetics
Products and services
- Össur Prosthetics and Bracing
- POWER KNEE
- i-Limb
- Cheetah Sports Blades
- Fior & Gentz Neuro Orthotics
- College Park Lower Limb Prosthetics
- Naked Prosthetics Finger Prostheses
- Odyssey iQ Foot
- ForMotion Patient Care Services
- Bracing & Supports
- Pro-Flex Prosthetic Feet
- Balance Foot Prostheses
- Proprio Foot
- Rheo Knee XC
Quantifiable outcome
- 22 medals won by para athletes using Össur technology at Paris 2024 Paralympics
- +3 more outcomes
Companies that use Embla Medical
Customer profileNamed customers9 records
Segments6 records
Ideal customer profiles4 records
Embla Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Embla Medical partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- Nordic CompassminorIndustry-led alliance to strengthen Nordic and European competitiveness, resilience and industrial innovation. Founding partner alongside companies including Novo Nordisk, EQT Group, Nokia, and others. First initiatives to be presented at Nordic Compass Summit in November 2026.
- Government of IcelandcoreThree-year partnership valued at USD 11 million to provide prosthetic care for up to 1,000 Ukrainian amputees through new Kyiv clinic. Co-financed by Government of Iceland and Embla Medical, with Future for Ukraine serving as implementing partner. Addresses unprecedented need with 50,000+ amputations since 2022 Russian invasion.
- Future for Ukraine (FFU)coreCharity organization serving as implementing partner for Ukraine prosthetic care initiative. Coordinating clinic operations and patient matching for up to 1,000 Ukrainian amputees.
- Streifeneder ortho.production GmbHcoreMajority share investment (51%) completed in September 2025 after regulatory approval. Positions Embla Medical as full-range provider and strengthens presence in key markets and less developed healthcare markets. Deal involved issuing new shares raising approximately EUR 12.5 million.
- NissanminorPartnership with Nissan for Richard Whitehead Foundation and Nissan Possibilities Project since 2021. Technical collaboration modified Nissan ARIYA for Richard Whitehead's prosthetic needs, enabling record-breaking Chicago Marathon performance.
- Protez Hub FoundationcoreUkrainian nonprofit organization spearheading educational efforts and championing sustainable development of limb prosthetics industry. Partnered for multi-disciplinary training of 19 Ukrainian medical professionals at Össur facility in Köln.
- ProsthetiKacoreNonprofit organization coordinating prosthetic assistance for Ukrainian amputees. Partnership to ensure ongoing rehabilitation and sustainable clinical care through local Ukrainian prosthetists.
- OttobockminorCo-founded Össur and Ottobock Research Trust Fund at University of Iceland with USD 150,000-500,000 funding per project for research on man-machine interfaces for prosthetic benefit.
- Alfred Mann FoundationminorAgreement to extend exploration of mind-controlled prosthetics technology for advanced neural control of prosthetic limbs.
- NikeminorNike Sole partnership on Össur Cheetah sports blade, combining Nike footwear technology with Össur prosthetic expertise for athletes.
- Danish National Olympic Committee & Sports ConfederationminorPartnership for para-athletic sponsorship and Olympic movement support in Denmark.
Scale indicators17 records
Recent moves8 records
Expansion highlights6 records
Embla Medical competitors and assessment
Company assessmentMarket position
Strengths1 record
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Embla Medical social profiles
Digital presenceEmbla Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Embla Medical leadership team
Management profileNumber of profiles
Profiles7 records
Embla Medical subsidiaries and ownership
Company hierarchySubsidiaries6 records
Embla Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Embla Medical M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Embla Medical
What does Embla Medical do?
Embla Medical designs, manufactures, and sells prosthetic limbs, neuro orthotic devices, and bracing & supports products through brands including Össur, Fior & Gentz, College Park, and Naked Prosthetics. The company also operates a global network of ForMotion Orthotic & Prosthetic patient care clinics providing prosthetic fitting, rehabilitation, and ongoing patient care services.
Is Embla Medical a public or private company?
Embla Medical is a public company. It is classified as public and is currently operating.
When was Embla Medical founded?
Embla Medical was founded in 1971. It employs 1,001 to 5,000 people.
Where is Embla Medical based?
Embla Medical is headquartered in Reykjavík, Iceland, in the Europe region.
How does Embla Medical make money?
Four revenue lines are on record. Prosthetics & Neuro Orthotics Products are the primary driver. The others are bracing & Supports, patient Care Services and strategic Acquisitions.
Does Embla Medical have an API?
No public API is recorded for Embla Medical.
What industry is Embla Medical in?
Embla Medical's product category is Orthotic and Prosthetic Medical Devices. Its primary akta.pro industry code is HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems), with a secondary code of HLAHAMAD, Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets). Its NAICS code is 339113 and its SIC code is 3842.